StopAfib.org interviews Dr. Daniel Singer, of Harvard Medical School.
Find more information on this topic, Dr. Singer, and a transcript of the interview, at:
http://stopafib.org/newsitem.cfm/NEWSID/394
In this video interview, Dr. Singer discussed topics covered in the stroke prevention in atrial fibrillation symposium he moderated at the Boston AF Symposium 2011. The topics discussed included the RE-LY trial of dabigatran, the ROCKET AF trial of rivaroxaban, and devices for keeping clots from forming in the left atrial appendage of the heart.
Dr. Singer is a Professor of Medicine at Harvard Medical School, Professor of Epidemiology at the Harvard School of Public Health, and Chief of the Clinical Epidemiology Unit at Massachusetts General Hospital.
Leave a Reply